{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADME prediction", "Acetohydrazonoyl cyanide", "Anticancer activity", "Bioisosterism", "Tubulin"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30197030", "DateCompleted": {"Year": "2019", "Month": "06", "Day": "03"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "09", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bmcl.2018.09.004", "S0960-894X(18)30735-2"], "Journal": {"ISSN": "1464-3405", "JournalIssue": {"Volume": "28", "Issue": "20", "PubDate": {"Year": "2018", "Month": "Nov", "Day": "01"}}, "Title": "Bioorganic & medicinal chemistry letters", "ISOAbbreviation": "Bioorg Med Chem Lett"}, "ArticleTitle": "(E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.", "Pagination": {"StartPage": "3350", "EndPage": "3355", "MedlinePgn": "3350-3355"}, "Abstract": {"AbstractText": ["A series of (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides have been synthesized and evaluated for their anticancer activity in human hepatocellular liver carcinoma HepG2 and breast adenocarcinoma MCF-7\u202fcell lines. Among all the tested compounds, compound 3a, 3e and 3n displayed more activity than lead compound with IC<sub>50</sub> value of 0.26-0.61\u202f\u03bcM. Meanwhile, these compounds (3a, 3e and 3n) showed potent antiproliferative activity against a panel of cancer cells and the HCT-8/T multidrug resistant cell line with IC<sub>50</sub> values in the range of 0.077- 7.44\u202f\u03bcM. Flow cytometric analyses revealed that compound 3n induced cell cycle arrest in G2/M phases in a dose dependent manner. The compound 3n also displayed potent tubulin polymerization inhibition with an IC<sub>50</sub> value of 0.9\u202f\u00b5M, with ten folds more active than colchicine (IC<sub>50</sub>\u202f=\u202f9\u202f\u03bcM). Molecular docking studies revealed that compound 3n efficiently interacted with the colchicine binding site of tubulin through hydrophobic, cation-\u03c0 and hydrogen bond interaction. Furthermore, in silico pharmacokinetic prediction shown that these compounds have a good ADME-related physicochemical parameters. These results demonstrate that 3n exhibits potent cytotoxicity in cancer cells by targeting the colchicine binding site of tubulin and potentially acts as a therapeutic lead compound for the development of anticancer drugs."], "CopyrightInformation": "Copyright \u00a9 2018. Published by Elsevier Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China; College of Chemistry and Chemical Engineering, Jishou University, Jishou 416000, PR China. Electronic address: wanggch123@163.com."}], "LastName": "Wang", "ForeName": "Guangcheng", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang 550004, China; College of Chemistry and Chemical Engineering, Jishou University, Jishou 416000, PR China."}], "LastName": "Peng", "ForeName": "Zhiyun", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Chemical Engineering, Jishou University, Jishou 416000, PR China."}], "LastName": "Peng", "ForeName": "Shanshan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Chemistry and Chemical Engineering, Jishou University, Jishou 416000, PR China."}], "LastName": "Qiu", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China. Electronic address: liyongjun_gmu@163.com."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Lan", "ForeName": "Yanyu", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Bioorg Med Chem Lett", "NlmUniqueID": "9107377", "ISSNLinking": "0960-894X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Hydrazones"}, {"RegistryNumber": "0", "NameOfSubstance": "Nitriles"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Tubulin Modulators"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "G2 Phase Cell Cycle Checkpoints"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Hydrazones"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Nitriles"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry"], "DescriptorName": "Tubulin"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Tubulin Modulators"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "7", "Day": "11"}, {"Year": "2018", "Month": "8", "Day": "17"}, {"Year": "2018", "Month": "9", "Day": "4"}, {"Year": "2018", "Month": "9", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "6", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "11", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30197030", "10.1016/j.bmcl.2018.09.004", "S0960-894X(18)30735-2"]}}]}